銅陵有色(000630.SZ):銅冠銅箔將於近日報送IPO審核問詢函的回覆報吿等
格隆匯 3 月 2日丨銅陵有色(000630.SZ)公佈,公司所屬控股子公司安徽銅冠銅箔集團股份有限公司(“銅冠銅箔”)於2020年12月29日收到深圳證券交易所(“深交所”)出具的《關於安徽銅冠銅箔集團股份有限公司首次公開發行股票並在創業板上市申請文件的審核問詢函》(審核函〔2020〕011042號)。銅冠銅箔會同各中介機構對問詢函所列問題進行了逐項落實、核查,將於近日向深交所報送《首次公開發行股票並在創業板上市申請文件審核問詢函之回覆報吿》並同步披露2020年度審計報吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.